It promotes proliferation and inhibits apoptosis in AML and chronic myeloid leukemia (CML) cells by targeting CTDSPL and TRIB2 (Khalaj et al., 2017; Zhang et al., 2013). This evidence concerns the gene CTDSPL and acute myeloid leukemia.